Selank 5MG

Selank 5MG

Selank (also known as U-50488H) is a synthetic peptide discovered in the late 1970s by researchers at the University of Illinois. It was initially developed for its potential anxiolytic and antidepressant properties, making it part of the broader class of peptides that can influence central nervous system function.

Research Context

Selank has been extensively studied in animal models to understand its mechanisms of action and effects on behavior. It is known for its ability to enhance cognitive functions such as memory and learning, as well as for its anxiolytic properties. The peptide also exhibits neuroprotective and anti-inflammatory activities, making it a subject of interest in the study of neurological disorders.

Research Overview

The research on Selank typically focuses on understanding its pharmacological profile, including its binding affinity to various receptors, such as GABAA receptors, which are crucial for neurotransmission. Studies often involve behavioral assays and molecular biology techniques to explore the peptide’s interactions with brain structures and potential therapeutic applications.

Key Research Focus Areas

• Cognitive Enhancement: Exploration of Selank’s role in improving memory and learning processes, often through animal behavior tests.
• Anxiety and Depression: Investigation into the peptide’s anxiolytic and antidepressant effects using various behavioral models.
• Neuroprotection: Study of Selank’s ability to protect neurons from damage, particularly in scenarios involving oxidative stress or neuroinflammation.
• Inflammatory Response Modulation: Analysis of how Selank influences inflammatory processes in the central nervous system.

Final Compliance Disclaimer

This product is intended for research use only. Not for human or animal consumption. Its use should be conducted under the guidance of a qualified researcher and within the legal framework applicable to your jurisdiction.